Tap into VigiLanz’s extensive rules library

Vigilanz

CLINICAL SURVEILLANCE COMBINED WITH REAL-TIME PATIENT POINT-OF-CARE CONTEXT

The CDC estimates that 20 to 50 percent of antibiotics prescribed in U.S. acute-care hospitals are unnecessary or inappropriate. With the need for healthcare systems and federal agencies to increase their focus on antibiotic stewardship, both providers and pharmacists play a vital role in monitoring safe and appropriate use. To address the problem, VigiLanz and IllumiCare have partnered to increase visibility within pharmacists’ and infection preventionists’ normal workflows around pharmacovigilance and clinical surveillance issues, including antimicrobial therapy.

EMR-AGNOSTIC

The VigiLanz app appears within IllumiCare’s Smart Ribbon – an EMR-agnostic, non-intrusive ribbon of information that hovers over the EMR and provides patient-specific information, making it more visible, convenient and accessible.

Rules -Based

Users are able to leverage the power of the VigiLanz rules engine to receive actionable alerts within clinical workflows to facilitate earlier intervention for optimal outcomes.

SAVE TIME & ENERGY

With the ability to respond to patient-specific context in real-time, users only receive notifications on the most important issues or opportunities, saving pharmacists both time and energy.

EMR-AGNOSTIC

The VigiLanz app appears within IllumiCare’s Smart Ribbon – an EMR-agnostic, non-intrusive ribbon of information that hovers over the EMR and provides patient-specific information, making it more visible, convenient and accessible.

Rules -Based

Users are able to leverage the power of the VigiLanz rules engine to receive actionable alerts within clinical workflows to facilitate earlier intervention for optimal outcomes.

SAVE TIME & ENERGY

With the ability to respond to patient-specific context in real-time, users only receive notifications on the most important issues or opportunities, saving pharmacists both time and energy.

VigiLanz provides real-time information related to safe antibiotic use that can reduce overprescribing or inappropriate prescribing and ultimately lower costs. By making this information easier to see, more actionable, and appropriately tailored to the person taking the action, antimicrobial stewardship efforts will be more successful.

One of the most important activations is the visibility of drug-bug mismatches, in which the antimicrobial a patient receives is not adequate for the microbiological organism presumed to be causing the clinical infection. Additionally, the VigiLanz app alerts highlight broad antimicrobial use, de-escalation opportunities, and conversion opportunities to move the patient to an antibiotic that has equal efficacy but is less expensive, such as from IV drugs to oral medications.

If you’re curious how VigiLanz might benefit your organization, let’s chat. 205.578.1738

Check out these other IllumiCare Apps

Slide

Slide